Acquisition
![CooperSurgical Buys Cook OB-GYN Assets](https://pharmtales.com/wp-content/uploads/2023/11/CooperSurgical-Finalizes-Reduced-Deal-for-Cook-Medical-OB-GYN-Division.jpg)
CooperSurgical Finalizes Reduced Deal for Cook Medical OB-GYN Division
The recent transaction announcement by CooperSurgical may resonate with familiarity as the company has just completed an acquisition of certain ...
![Otsuka, psychedelics, Mindset Pharma, M&A, Acquisition, MSP-1014](https://pharmtales.com/wp-content/uploads/2023/09/Otsuka-acquires-Mindset-Pharma-a-leader-in-psychedelic-medicines-for-mental-health.jpg)
Otsuka acquires Mindset Pharma, a leader in psychedelic medicines for mental health
Japanese pharmaceutical giant Otsuka is embarking on a groundbreaking acquisition, setting its sights on Canada’s Mindset Pharma, a specialist in ...
![Danaher, Abcam, Antibody Portfolio, Acquisition, M&A, Danaher Buys Abcam](https://pharmtales.com/wp-content/uploads/2023/08/Abcams-Harmonious-Acquisition-by-Danaher-Shaping-the-Future-of-Antibody-Research.jpg)
Abcam’s Harmonious Acquisition by Danaher Shaping the Future of Antibody Research
In the realm where science meets commerce, a symphony of strategy and innovation is playing out. Just two months since ...
![LEO Pharma, M&A, Timber Pharmaceuticals, Acquisition](https://pharmtales.com/wp-content/uploads/2023/08/LEO-Pharma-Set-to-Acquire-Timber-Pharmaceuticals.jpg)
LEO Pharma Set to Acquire Timber Pharmaceuticals
Timber Pharmaceuticals has exciting news to shareāthe company is set to be acquired by LEO US Holding, Inc., a wholly-owned ...
![Biogen, Reata Pharmaceuticals, M&A, acquisition,](https://pharmtales.com/wp-content/uploads/2023/08/Biogen-Outbids-Competitor-in-7.3-Billion-Reata-Pharmaceuticals-Acquisition-Duel.jpg)
Biogen Outbids Competitor in $7.3 Billion Reata Pharmaceuticals Acquisition Duel
In a surprising turn of events, Biogen’s acquisition of Reata Pharmaceuticals for $7.3 billion raised eyebrows among industry observers last ...
![Novartis Buys Chinook Therapeutics for $1.7 Billion](https://pharmtales.com/wp-content/uploads/2023/08/Novartis-Acquires-Chinook-Therapeutics-for-USD-3.5-Billion-to-Boost-its-Renal-Portfolio.jpg)
Novartis Acquires Chinook Therapeutics for USD 3.5 Billion to Boost its Renal Portfolio
Novartis, a global pharmaceutical giant, has finalized its deal to buy Chinook Therapeutics, a biotech company that specializes in developing ...
![Qunol Joins Sanofi in a Major Healthy Aging Deal](https://pharmtales.com/wp-content/uploads/2023/07/Qunol-a-rapidly-expanding-US-brand-in-the-healthy-aging-market-will-be-acquired-by-Sanofi.jpg)
Qunol, a rapidly expanding US brand in the healthy aging market, will be acquired by Sanofi
Source – Sanofi Paris, July 28, 2023. Sanofi announces its strategic move to acquire Qunol, a renowned and leading brand ...
![Sosei Buys Idorsiaās Japan and Korea Units for $466 Million](https://pharmtales.com/wp-content/uploads/2023/07/In-a-466-million-agreement-Sosei-acquires-the-Japan-and-Korea-subsidiaries-of-Idorsia.jpg)
In a $466 million agreement, Sosei acquires the Japan and Korea subsidiaries of Idorsia
Source – Sosei Heptares Japan’s Sosei Group has successfully transformed into a commercial-stage pharmaceutical company by acquiring the rights to ...
![Phreesia Acquires MediFind to Enhance Patient Experience and Outcomes](https://pharmtales.com/wp-content/uploads/2023/07/Phreesia-Acquires-MediFind-to-Enhance-Patient-Experience-and-Outcomes.jpg)
Phreesia Acquires MediFind to Enhance Patient Experience and Outcomes
Phreesia, a software as a service (SaaS) firm specializing in life sciences and healthcare, has announced its acquisition of MediFind, ...
![CDC to review Sanofiās Beyfortus RSV antibody in August](https://pharmtales.com/wp-content/uploads/2023/07/The-CDC-vaccination-committee-has-scheduled-a-date-in-August-to-consider-using-Sanofi-Arizonas-Beyfortus-RSV-antibody.jpg)
The CDC vaccination committee has scheduled a date in August to consider using Sanofi, Arizona’s Beyfortus RSV antibody
Following its highly anticipated FDA approval on Monday, the respiratory syncytial virus (RSV) antibody developed by Sanofi and AstraZeneca is ...
![Novartis Acquires DTx Pharma to Boost xRNA Platform and Neuroscience Pipeline](https://pharmtales.com/wp-content/uploads/2023/07/Novartis-Acquires-DTx-Pharma-to-Boost-xRNA-Platform-and-Neuroscience-Pipeline.jpg)
Novartis Acquires DTx Pharma to Boost xRNA Platform and Neuroscience Pipeline
Source – Novartis On July 17, Novartis made an announcement regarding its recent acquisition of DTx Pharma, a biotechnology company ...
![Roche's Potential $7billion Acquisition_ Exploring the Purchase of Roivant's Promising Drug](https://pharmtales.com/wp-content/uploads/2023/07/Roches-Potential-7billion-Acquisition_-Exploring-the-Purchase-of-Roivants-Promising-Drug.jpg)
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
![Sigilon Therapeutics will be acquired by Lilly | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Sigilon-Therapeutics-will-be-acquired-by-Lilly.jpg)
Sigilon Therapeutics will be acquired by Lilly
Source – Eli Lilly On June 29, 2023 Eli Lilly and Company and Sigilon Therapeutics entered into a definitive agreement, ...
![Bellus Health Acquired by GSK is complete - Pharmtales - Latest Pharma News & Analysis](https://pharmtales.com/wp-content/uploads/2023/06/Bellus-Health-Acquired-by-GSK-is-complete-Pharmtales-Latest-Pharma-News-Analysis.jpg)
Bellus Health Acquired by GSK is completeĀ
Source – GSK On 28 June 2023, GSK and BELLUS Health announced the completion of GSK’s acquisition of BELLUS through ...
![DICE Therapeutics will be acquired by Lilly in order to advance immunology innovation](https://pharmtales.com/wp-content/uploads/2023/06/DICE-Therapeutics-will-be-acquired-by-Lilly-in-order-to-advance-immunology-innovation.jpg)
DICE Therapeutics will be acquired by Lilly in order to advance immunology innovation
Source – Eli Lilly On June 20, 2023 a formal deal for Lilly to purchase DICE was announced by Eli ...
![Merck Completes Acquisition of Prometheus Biosciences, Expanding Pipeline with Potential Breakthrough Treatment](https://pharmtales.com/wp-content/uploads/2023/06/Merck-Completes-Acquisition-of-Prometheus-Biosciences-Expanding-Pipeline-with-Potential-Breakthrough-Treatment.jpg)
Merck Completes Acquisition of Prometheus Biosciences, Expanding Pipeline with Potential Breakthrough Treatment
Source: Merck On June 16, 2023, Merck announced the successful completion of its acquisition of Prometheus Biosciences, making Prometheus a ...
![Pfizer updates papers for its $43 billion acquisition of Seagen as the FTC keeps a watch on biopharma M&A deals](https://pharmtales.com/wp-content/uploads/2023/06/Pfizer-updates-papers-for-its-43-billion-acquisition-of-Seagen-as-the-FTC-keeps-a-watch-on-biopharma-MA-deals-1.jpg)
Pfizer updates papers for its $43 billion acquisition of Seagen as the FTC keeps a watch on biopharma M&A deals
Source: Pfizer A month later, Pfizer withdrew its notice for its proposed $43 billion acquisition of cancer medication expert Seagen ...